Company intelligence / Profile preview

Trident Capital

San Mateo, California, United States

Ownership: Private
Development stage: Other

Overview

Trident Capital is a venture capital firm founded in 1993 that specializes in investments in the healthcare IT, cybersecurity, and enterprise software sectors. While not a drug development company itself, the firm has been a significant player in the healthcare space through its investments in clinical services, health information technology, and digital health platforms. Notable healthcare-related portfolio companies have included Teladoc, Healthline, and Syapse. The firm's investment strategy focuses on growth-stage companies that leverage technology to improve efficiency and outcomes in the healthcare delivery system. Trident Capital has historically operated multiple funds and has spun off specialized teams into new entities like Forgepoint Capital.

Industry: Investors

Beyond the preview

Go deeper on Trident Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trident Capital.

Explore the full profile